Developmental Immunotoxicity in Nonhuman Primates

Immunotoxicology Strategies for Pharmaceutical Safety Assessment

Volumn , Issue , 2008, Pages 299-317

  Martin, Pauline L ^a   Buse, Eberhard ^b  

^a CENTOCOR INC   (United States)

^b Developmental and Reproductive Toxicology   (Germany)

Author keywords

Developmental immunotoxicity in primates; Immune system postnatal development; Nonhuman primate developmental immunotoxicity assessment

Indexed keywords

EID: 67649249356     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470386385.ch22     Document Type: Chapter

References (43)

1. Aaltonen R, Heikkinen T, Hakala K, Laine K, Alanen A. Transfer of proinflammatory cytokines across the term placenta. Obstet Gynecol 2005;106:802-808.
2. Bommhardt U, Beyer M, Hünig T, Reichardt HM. Molecular and cellular mechanisms of T-cell development. Cell Mol Life Sci 2004;61:263-280.
3. Buse E. Development of the immune system in the cynomolgus monkey: the appropriate model in human targeted toxicology? Immunotoxicol 2005;2:211-216.
4. Buse E, Habermann G, Osterburg I, Korte R, Weinbauer GF. Reproductive/developmental toxicity and immunotoxicity assessment In the nonhuman primate model. Toxicology 2003;185:221-227.
5. Buse E, Habermann G, Vogel F. Thymus development in Macaca fascicularis (Cynomolgus monkey): an approach for toxicology and embryology. J Mol Hist 2006;37:161-170.
6. Coe CL, Kemnitz JW, Scneider ML. Vulnerability of placental antibody transfer and fetal complement synthesis to disturbance of the pregnant monkey. J Med Primatol 1993;22:294-300.
7. Coe CL, Lubach GR, Izard KM. Progressive improvement in the transfer of maternal antibody across the order primates. Am J Primatol 1994;32:51-55.
8. Colucci F, Caligiuri MA, DiSanto JP. What does it take to make a natural killer? Nat Rev Immunol 2003;3:413-425.
9. Dietert RR, Holsapple MP. Methodologies for developmental immunotoxicity (DIT) testing. Methods 2007;41:123-131.
10. Dietert RR, Etzel RA, Chen D, Halonen M, Holladay SD, Jarabek AM, Landreth K, Peden DB, Pinkerton K, Smialowicz RJ, Zoetis T. Workshop to identify critical windows of exposure for children ' s health: Immune and Respiratory Systems Work Group summary. Environ Health Perspect 2000;108:483-490.
11. Firan M, Bawdon R, Radu C, Ober RJ, Eaken D, Antohe F, Ghetie V, Ward ES. The MHC class I-related receptor FcRn, plays and essential role in the maternofetal transfer of γ-globin in humans. Int Immunol 2001;13:993-1002.
12. Fujimoto K, Terao K, Cho F, Honjo S. The placental transfer of IgG in the cynomolgus monkey. Jpn J Med Sci Biol 1983;36:171-176.
13. Gregor H, Egarter C, Levin D, Sternberger B, Heinze G, Leitich H, Reisenberger K. The passage of granulocyte-macrophage colony-stimulating factor across the human placenta perfused in vitro. J Soc Gynecol Invest 1999;6:307-310.
14. Haley PJ. Species differences in the structure and function of the immune system. Toxicology 2003;188:49-71.
15. Henck J, Hilbish KG, Serabian MA, Cavagnaro JA, Hendrickx AG, Agnish ND, Kung AHC, Mordenti J. Reproductive toxicity testing of therapeutic biotechnology agents. Teratology 1996;53:185-195.
16. Hendrie TA, Peterson PA, Short JJ, Tarantal AF, Rothgarn E, Hendrie MI, Hendrickx AG. Frequency of prenatal loss in a macaque breeding colony. Am J Primatol 1996;40:41-53.
17. Hendrickx AG, Makori N, Peterson P. The nonhuman primate as a model of developmental immunotoxicity. Hum Exp Toxicol 2002;21:537-542.
18. Hendrickx AG, Peterson PE, Makori NM. The nonhuman primate as a model of developmental immunotoxicity. In Developmental Immunotoxicology, edited by Halladay SD, pp. 117-136. Boca Raton, FL : CRC Press, 2005.
19. Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T. Coexpression of stem cell factor and c-kit genes in small-cell lung cancer. Oncogene 1991;6:2291-2296.
20. Hinrichsen KV. Intestinaltrakt. Human-Embryologie. Berlin, Germany : Springer-Verlag, 1990.
21. Holladay SD, Smialowicz RJ. Development of the murine and human immune system:differential effects of immunotoxicants depend on the time of exposure. Environ Health Perspect 2000;108:463-473.
22. Holsapple MP, West LJ, Landreth KS. Species comparison of anatomical and functional immune system development. Birth Defects Res 2003;68:321-334.
23. Hummler H, Korte R, Hendrickx AG. Induction of malformations in the cynomolgus monkey with 13-cis retoic acid. Teratology 1990;42:263-272.
24. ICH (International Conference on Harmonization). Guidance for Industry. S8 Immunotoxicity Studies for Human Pharmaceuticals, 2006.
25. Korte R, Hummler H, Hendrickx AG. Importance of early exposure to 13-cis retinoic acid to induce teratogenicity in the cynomolgus monkey. Teratology 1993;47:37-45.
26. Makori N, Peterson PE, Lantz K, Hendrickx AG. Exposure of cynomolgus monkey embryos to retinoic acid causes thymic defects: effects on peripheral lymphoid organ development. J Med Primatol 2002;31:91-97.
27. Makori N, Tarantal AF, LüFX, Rourke T, Mathas ML, McChesney MB, Hendrickx AG, Miller CJ. Functional and morphological development of lymphoid tissues and immune regulatory and effector function in Rhesus monkeys: cytokine-secreting cells, immunoglobulin-secreting cells, and CD5 + B-1 cells appear early in fetal development. Clin Diag Lab Immunol 2003;10:140-153.
28. Malek A, Sager R, Schneider H. Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy. Am J Reprod Immunol 1994;32:8-14.
29. Malek A, Sager R, Kuhn P, Nicholaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996;36:248-255.
30. Martin PL, Oneda S, Treacy G. Effects of an anti-TNF α monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system. Am J Reprod Immunol 2007;58:138-149.
31. Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Sugiura T, Ariyoshi Y, Takahashi TRU. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 1993;1:339-346.
32. Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol 2004;224:2731-2738.
33. Michie AM, Carlyle JR, Schmitt TM, Ljutic B, Cho SK, Fong Q, Zuniga-Pflücker JC. Clonal characterization of a bipotent T cell and NK cell progenitor in the mouse fetal thymus. J Immunol 2000;164:1730-1733.
34. Miller RK, Mace K, Polliotti B, DeRita R, Hall W, Treacy G. Marginal transfer of ReoPro (abciximab) compared with immunolglobulin G (F105), Inulin and water in the perfused human placenta in vitro. Placenta 2003;24:727-738.
35. Price KD, Mezza L, Diters R, Wells S, DeVona D, Tzogas Z, Haggerty H. Development and immunomodulation of delayed-type hypersensitivity (DTH) in cynomolgus monkeys. 2004 ; 78 : 431.
36. Reisenberger K, Egarter C, Vogl S, Sternberger B, Kiss H, Husslein P. The transfer of interleukin-8 across the human placenta perfused in vitro. Obstet Gynecol 1996;87:613-616.
37. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003;21:3365-3369.
38. Van de Perre P. Transfer of antibody via mother ' s milk. Vaccine 2003;21:3374-3376.
39. Van der Aa E, Copius Peereboom-Stegeman JHJ. Noordhoek J, Gibnau WJ, Russel FGM. Mechanisms of drug transfer across the human placenta. Pharm World Sci 1998;20:139-148.
40. Vogel F, Bee W. Reproduction toxicology in primates: an overview of methods and techniques. In: Reproduction in Nonhuman Primates, edited by Weinbauer GF, Korte R, pp. 95-110. Münster, Germany : Waxmann Press, 1999.
41. Weinbauer GF. The nonhuman primate as a model in developmental and reproductive toxicology. In: Primate Models in Pharmaceutical Drug Development, edited by Korte R, Vogel F, and Weinbauer GF, pp. 49-64. Münster, Germany : Waxmann Press, 2002.
42. West LJ. Defining critical windows in the development of the human immune system. Hum Exp Toxicol 2002 ; 21 ; 499-505.
43. Zuniga-Pflücker JC. T-cell development made simple. Nat Rev Immunol 2004;4:67-72.